Screener
Icahn Enterprises IEP Pharma — Other Operating Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Icahn Enterprises in its filing.
Tagged under the XBRL concept iep:OtherOperatingRevenue.
The source filing: Icahn Enterprises’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-090605
| Line item | Investment | Energy | Automotive | Food Packaging | Real Estate | Home Fashion | Pharma | Holding Company | Consolidated |
|---|---|---|---|---|---|---|---|---|---|
| Revenues: | |||||||||
| Net sales | — | $2,738 | $199 | $90 | — | $39 | $15 | — | $3,081 |
| Other revenues from operations | — | — | 154 | — | 19 | — | 2 | — | 175 |
| Net loss from investment activities | (334) | — | — | — | — | — | — | — | (334) |
| Interest and dividend income | 31 | 6 | — | — | 5 | — | — | 7 | 49 |
| (Loss) gain on disposition of assets, net | — | (2) | 1 | — | — | — | — | — | (1) |
| Other income (loss), net | — | 3 | — | — | 3 | (1) | — | — | 5 |
| (303) | 2,745 | 354 | 90 | 27 | 38 | 17 | 7 | 2,975 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Icahn Enterprises's pharma — other operating revenue?
- Icahn Enterprises (IEP) reported pharma — other operating revenue of $2M in Q2 2026.
- How has Icahn Enterprises's pharma — other operating revenue changed year-over-year?
- Icahn Enterprises's pharma — other operating revenue increased by 100.0% year-over-year, from $1M to $2M.
- What is the long-term trend for Icahn Enterprises's pharma — other operating revenue?
- Over 4 years (2021 to 2025), Icahn Enterprises's pharma — other operating revenue has grown at a 5.7% compound annual growth rate (CAGR), from $4M to $5M.
- What does pharma — other operating revenue mean?
- Revenue generated by the pharmaceutical segment from activities outside of direct product sales, such as licensing fees, royalties, or contract manufacturing services. It provides insight into the diversification of the segment's income streams beyond core product distribution.
Ask your AI about Icahn Enterprises's pharma — other operating revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude